NVAX Stock Climbs as Novavax Settles Covid-19 Vaccine Dispute

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Novavax stock is climbing higher on Thursday as investors in NVAX shares react to it reaching a $475 million settlement with Gavi.

The post NVAX Stock Climbs as Novavax Settles Covid-19 Vaccine Dispute appeared first on InvestorPlace.

• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.